Effect of fluticasone in severe polyposis - PubMed (original) (raw)
Clinical Trial
Effect of fluticasone in severe polyposis
V J Lund et al. Arch Otolaryngol Head Neck Surg. 1998 May.
Abstract
Objectives: To investigate the effect of intranasal corticosteroids in the treatment of polyps in patients with severe polyposis listed for surgical treatment and to determine the treatment effect on the progression of the disease.
Design: A double-blind, randomized, parallel-group, placebo-controlled, 12-week study at a single center.
Setting: A tertiary referral center in London, England.
Patients: Thirty-four patients with severe polyposis listed for endoscopic surgical treatment.
Intervention: By random allocation, fluticasone propionate aqueous nasal spray (FPANS), 200 microg twice a day; beclomethasone dipropionate aqueous nasal spray, 200 microg twice a day; or placebo nasal spray twice a day was administered. Patients received 2 actuations to each nostril in the morning and in the evening.
Main outcome measures: Efficacy end points were the need for polypectomy at the end of treatment, the results of acoustic rhinometry, the polyp score, the peak nasal inspiratory flow rate, and an assessment of symptoms.
Results: The polyp score was significantly decreased in the FPANS-treated group (P < or = .01). The nasal cavity volume was significantly increased in both the FPANS-treated group and the group receiving beclomethasone compared with placebo (P < or = .01) at the end of treatment. The percentage change in the mean morning peak nasal inspiratory flow rate was greater in the FPANS-treated group, with a significant effect observed at week 2 (P = .01). Nasal blockage was significantly decreased in both active groups compared with the group receiving placebo. No significant difference was observed between the treatment groups in the number of patients requiring polypectomy.
Conclusions: Fluticasone and beclomethasone aqueous nasal sprays are effective in treating the symptoms of severe nasal polyps. There was some evidence that the group treated with FPANS responded more quickly to intervention and that the magnitude of the response was greater than in the group receiving beclomethasone.
Similar articles
- Fluticasone propionate aqueous nasal spray in the treatment of nasal polyposis.
Holmberg K, Juliusson S, Balder B, Smith DL, Richards DH, Karlsson G. Holmberg K, et al. Ann Allergy Asthma Immunol. 1997 Mar;78(3):270-6. doi: 10.1016/s1081-1206(10)63180-8. Ann Allergy Asthma Immunol. 1997. PMID: 9087151 Clinical Trial. - A placebo-controlled study of fluticasone propionate aqueous nasal spray and beclomethasone dipropionate in perennial rhinitis: efficacy in allergic and non-allergic perennial rhinitis.
Scadding GK, Lund VJ, Jacques LA, Richards DH. Scadding GK, et al. Clin Exp Allergy. 1995 Aug;25(8):737-43. doi: 10.1111/j.1365-2222.1995.tb00011.x. Clin Exp Allergy. 1995. PMID: 7584685 Clinical Trial. - Once daily fluticasone propionate is as effective for perennial allergic rhinitis as twice daily beclomethasone diproprionate.
van As A, Bronsky EA, Dockhorn RJ, Grossman J, Lumry W, Meltzer EO, Seltzer JM, Rogenes PR. van As A, et al. J Allergy Clin Immunol. 1993 Jun;91(6):1146-54. doi: 10.1016/0091-6749(93)90317-9. J Allergy Clin Immunol. 1993. PMID: 8509578 Clinical Trial. - Treatment of seasonal allergic rhinitis with fluticasone propionate aqueous nasal spray: review of comparator studies.
Storms WW. Storms WW. Allergy. 1995;50(23 Suppl):25-9. doi: 10.1111/j.1398-9995.1995.tb02738.x. Allergy. 1995. PMID: 7604951 Review. - Intranasal fluticasone propionate. A reappraisal of its pharmacology and clinical efficacy in the treatment of rhinitis.
Wiseman LR, Benfield P. Wiseman LR, et al. Drugs. 1997 May;53(5):885-907. doi: 10.2165/00003495-199753050-00014. Drugs. 1997. PMID: 9129872 Review.
Cited by
- The Inhibition Effect and Mechanism of Staurosporine Isolated from Streptomyces sp. SNC087 Strain on Nasal Polyp.
Choi G, Lee EY, Chung D, Cho K, Yu WJ, Nam SJ, Park SK, Choi IW. Choi G, et al. Mar Drugs. 2024 Jan 11;22(1):39. doi: 10.3390/md22010039. Mar Drugs. 2024. PMID: 38248664 Free PMC article. - Medical Management Strategies in Acute and Chronic Rhinosinusitis.
Cho SH, Ledford D, Lockey RF. Cho SH, et al. J Allergy Clin Immunol Pract. 2020 May;8(5):1559-1564. doi: 10.1016/j.jaip.2020.02.020. Epub 2020 Mar 3. J Allergy Clin Immunol Pract. 2020. PMID: 32142965 Free PMC article. - Causality Assessment of Olfactory and Gustatory Dysfunction Associated with Intranasal Fluticasone Propionate: Application of the Bradford Hill Criteria.
Muganurmath CS, Curry AL, Schindzielorz AH. Muganurmath CS, et al. Adv Ther. 2018 Feb;35(2):173-190. doi: 10.1007/s12325-018-0665-5. Epub 2018 Feb 2. Adv Ther. 2018. PMID: 29396682 Free PMC article. Review. - Chronic Rhinosinusitis with Nasal Polyps.
Stevens WW, Schleimer RP, Kern RC. Stevens WW, et al. J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):565-72. doi: 10.1016/j.jaip.2016.04.012. J Allergy Clin Immunol Pract. 2016. PMID: 27393770 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources